Effects of ezetimibe and simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear cells: a randomized controlled study in healthy men

Trial Profile

Effects of ezetimibe and simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear cells: a randomized controlled study in healthy men

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2010

At a glance

  • Drugs Ezetimibe; Simvastatin
  • Indications Cardiovascular disorders; Cystic fibrosis; Diabetic cardiomyopathy; Hypercholesterolaemia; Hyperlipoproteinaemias; Hypertriglyceridaemia; Low HDL cholesterol; Multiple sclerosis; Sitosterolaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2010 Results were reported at the ESC Congress 2010: Annual Congress of the European Society of Cardiology.
    • 01 May 2008 Results published in Atherosclerosis.
    • 01 May 2008 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top